These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 11536305

  • 1. Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells.
    Lanzi C, Cassinelli G, Cuccuru G, Supino R, Zuco V, Ferlini C, Scambia G, Zunino F.
    Prostate; 2001 Sep 15; 48(4):254-64. PubMed ID: 11536305
    [Abstract] [Full Text] [Related]

  • 2. Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.
    Cassinelli G, Lanzi C, Supino R, Pratesi G, Zuco V, Laccabue D, Cuccuru G, Bombardelli E, Zunino F.
    Clin Cancer Res; 2002 Aug 15; 8(8):2647-54. PubMed ID: 12171897
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.
    Li W, Fan J, Banerjee D, Bertino JR.
    Mol Pharmacol; 1999 Jun 15; 55(6):1088-93. PubMed ID: 10347252
    [Abstract] [Full Text] [Related]

  • 4. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
    Gupta S, Hussain T, Mukhtar H.
    Arch Biochem Biophys; 2003 Feb 01; 410(1):177-85. PubMed ID: 12559991
    [Abstract] [Full Text] [Related]

  • 5. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
    Zuco V, Supino R, De Cesare M, Carenini N, Perego P, Gatti L, Pratesi G, Pisano C, Martinelli R, Bucci F, Zanier R, Carminati P, Zunino F.
    Biochem Pharmacol; 2003 Apr 15; 65(8):1281-94. PubMed ID: 12694869
    [Abstract] [Full Text] [Related]

  • 6. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH, Burnstein KL.
    Endocrinology; 1998 Mar 15; 139(3):1197-207. PubMed ID: 9492054
    [Abstract] [Full Text] [Related]

  • 7. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest.
    Ikezoe T, Chen SS, Heber D, Taguchi H, Koeffler HP.
    Prostate; 2001 Dec 01; 49(4):285-92. PubMed ID: 11746275
    [Abstract] [Full Text] [Related]

  • 8. Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis.
    Stewart ZA, Mays D, Pietenpol JA.
    Cancer Res; 1999 Aug 01; 59(15):3831-7. PubMed ID: 10447002
    [Abstract] [Full Text] [Related]

  • 9. A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes.
    Cassinelli G, Supino R, Perego P, Polizzi D, Lanzi C, Pratesi G, Zunino F.
    Int J Cancer; 2001 Jun 01; 92(5):738-47. PubMed ID: 11340581
    [Abstract] [Full Text] [Related]

  • 10. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
    Schmidt M, Fan Z.
    Oncogene; 2001 Sep 27; 20(43):6164-71. PubMed ID: 11593424
    [Abstract] [Full Text] [Related]

  • 11. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
    Motwani M, Li X, Schwartz GK.
    Clin Cancer Res; 2000 Mar 27; 6(3):924-32. PubMed ID: 10741717
    [Abstract] [Full Text] [Related]

  • 12. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
    Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R.
    Oncogene; 2001 Jan 11; 20(2):147-55. PubMed ID: 11313944
    [Abstract] [Full Text] [Related]

  • 13. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 14. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.
    Oncogene; 2001 May 24; 20(23):2927-36. PubMed ID: 11420705
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells.
    Héliez C, Baricault L, Barboule N, Valette A.
    Oncogene; 2003 May 22; 22(21):3260-8. PubMed ID: 12761496
    [Abstract] [Full Text] [Related]

  • 16. Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line.
    Panvichian R, Orth K, Pilat MJ, Day ML, Day KC, Yee C, Kamradt JM, Pienta KJ.
    Urology; 1999 Oct 22; 54(4):746-52. PubMed ID: 10510942
    [Abstract] [Full Text] [Related]

  • 17. Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel.
    Cassinelli G, Supino R, Zuco V, Lanzi C, Scovassi AI, Semple SC, Zunino F.
    Biochem Pharmacol; 2004 Sep 01; 68(5):923-31. PubMed ID: 15294455
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel.
    Sobue S, Mizutani N, Aoyama Y, Kawamoto Y, Suzuki M, Nozawa Y, Ichihara M, Murate T.
    Biochem Biophys Res Commun; 2016 Oct 28; 479(4):808-813. PubMed ID: 27687545
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.
    Henley D, Isbill M, Fernando R, Foster JS, Wimalasena J.
    Cancer Chemother Pharmacol; 2007 Feb 28; 59(2):235-49. PubMed ID: 16972069
    [Abstract] [Full Text] [Related]

  • 20. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P, Robey R, Fojo T, Blagosklonny MV.
    Oncogene; 2001 Jun 28; 20(29):3806-13. PubMed ID: 11439344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.